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Abstract
The St. George’s Respiratory Questionnaire (SGRQ) and chronic obstructive pulmonary disease (COPD)
assessment test (CAT) are the measures used to assess health status. This study aims to examine the
responsiveness of these tools by severity of dyspnoea category in patients with COPD. Forty-nine COPD
patients who underwent a 12-week pulmonary rehabilitation (PR) programme were assessed at baseline,
12 weeks and at 28-week follow-up. Patients were categorized into two groups by severity of dyspnoea
category (i.e. mild to moderate (modified Medical Research Council (mMRC) 1–2) and severe to very severe
(mMRC 3–4)) using the mMRC dyspnoea scale. Effect size (ES) was computed as estimates of responsiveness. The
SGRQ demonstrated greater responsiveness by total sample (SGRQ, ES ¼ 0.87; CAT, ES ¼ 0.75) and for the
mMRC 3–4 category (SGRQ, ES ¼ 0.91; CAT, ES ¼ 0.76) on completion of PR. At 28-week follow-up, overall
comparable responsiveness of the CAT and SGRQ was identified by total sample (SGRQ, ES ¼ 0.75; CAT,
ES ¼ 0.74) and by severity of dyspnoea category. The symptom, impact and activity domains of the SGRQ
showed good responsiveness, with greater ESs obtained overall for the mMRC 3–4 category. On completion of
PR, the SGRQ demonstrates a greater responsiveness with COPD patients, especially in relation to the mMRC
3–4 category, while both the CAT and SGRQ show comparable responsiveness on follow-up.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a
devastating respiratory condition and a major cause of
morbidity and mortality.1,2 Taking into account the
fact that a complete cure is not possible, patients
undergo intensive pulmonary rehabilitation (PR), an
evidence-based intervention which is identified as one
of the major interventions for the management
of COPD.3 One of the major aims of PR is that of
ameliorating the health-related quality of life of
individuals with chronic respiratory impairment.2,4–7
Two questionnaires commonly used within
the care of COPD patients are the St. George’s
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Respiratory Questionnaire (SGRQ)8,9 and COPD
assessment test (CAT).10,11 Clinically, the SGRQ has
been demonstrated to be an important tool to quantify
the impact of COPD on symptoms, functional mea-
sures and general well-being of the patient,12,13 as
well as in evaluating the effectiveness of healthcare
services.14 Despite this, the SGRQ is considered to be
long, complex and time-consuming to complete.15 The
CAT was developed in order to have a short and easy
tool which could be administered in the clinical
setting.11 It is a validated tool measuring and quantify-
ing the impact or burden of COPD on the individual.16
Both tests have been compared individually for
changes in health status following PR,17 with evidence
for responsiveness7,18,19 identified for both tools. The
responsiveness of a tool is considered an important
property when choosing a questionnaire, as it detects
the capacity of the tool to detect change over time.20,21
When assessing changes in health status before and
after an intervention, responsiveness is an expression
of the ability of that tool to detect any differences
between the questionnaire scores, in a manner which
reflects the change that would have taken place.22,23
The need to identify a tool having a good respon-
siveness is of importance for COPD patients, consid-
ering that between 8.3% and 49.6% of those referred
for PR do not attend and between 9.7% and 31.8% fail
to complete the programme.24 Obstacles cited by
COPD patients in relation to non-completion of PR
include severity of breathlessness, transportation dif-
ficulties, depression, programme perceived as too
long and lack of perceived benefit.24,25 Consequently,
there is a need to identify a tool that has a good
responsiveness in relation to health status measures,
such as the severity of breathlessness, which has been
identified as a significant predictor of non-completion
of PR programmes. This would also facilitate the
introduction of individualized PR programmes to
enhance adherence, as recommended by the UK
National Audit on PR.26
This article reports a study that aims to contribute to
the existing literature, by examining the responsiveness
of the CAT and SGRQ, on stable COPD patients
categorized by dyspnoea severity level, following a
12-week PR programme and at 28-week follow-up.
Methods
A quantitative, longitudinal study was conducted.
Data were collected at baseline, on completion of
PR at 12 weeks and at 28-week follow-up.
Study design and participants
Seventy-five patients (59 males and 16 females) with
a confirmed diagnosis of COPD were referred from
the medical wards and respiratory outpatient clinic of
the local general hospital. The definition of COPD
adopted for this study was provided by the American
Thoracic Society/European Respiratory Society
Guidelines.27 Patients had a self-reported smoking
history, clinical signs and symptoms together with
spirometry readings which were consistent with
COPD and exertional dyspnoea (modified Medical
Research Council (mMRC) dyspnoea score – grade
1 or above). These participants were all found to be
medically stable by the respiratory physicians and
free from exacerbations in the 3 months preceding
enrolment into PR. Inclusion criteria to the rehabilita-
tion programme included oxygen saturations of >92%
at rest, stable cardiovascular system and no neurolo-
gical or orthopaedic problems which could interfere
with rehabilitation. Additionally, participants who
required modifications to their drug therapy due to
exacerbations were excluded from the study.
Rehabilitation programme
The rehabilitation programme consisted of twice
weekly 2-hour sessions, over 12 weeks. The exercise
session consisted of a warm-up period, treadmill
walking, with the initial speed devised from the
distance obtained from the 6-minute walk test and
gradually increased throughout the weeks, step-
climbing, arm ergometry, cycling using a stationary
bike and also upper and lower limb strengthening
exercises using weights. Inspiratory muscle training
was also carried out using the Respironics inspira-
tory muscle trainer (IMT) Threshold trainer1 for 15
minutes during the class. All participants were
instructed to carry the IMT at home for 30 minutes,
5 days per week. A home exercise programme was
also provided to the patients. Educational sessions
were conducted on aspects of COPD care and self-
management by medical doctors, psychologists, phy-
siotherapists, dieticians and respiratory nurses. These
sessions were monitored by a home diary system pro-
vided to each participant at the start of the programme.
Questionnaires
Patients were assessed 2 weeks before enrolling into
the programme (i.e. at baseline), on completion of the
12-week PR programme and during the follow-up
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phase at 28 weeks. Health status measures were
obtained using the SGRQ8 and CAT.10
The SGRQ8 consists of 50 items, within three sec-
tions representing the symptom, activity and impact
domains. The scores range from 0 to l00 for the three
subscales with a summary total score. Higher scores
indicate worse health status; 0 indicates no impairment
and 100 indicates maximal impairment.9 The SGRQ
has been shown to have an adequate inter-rater relia-
bility and reproducibility as well as the ability to show
responsiveness to quantify change over time.9
The CAT11 assesses several aspects affecting
COPD patients ranging from symptoms, health status
and well-being. Each question presents with a state-
ment with a rating ranging from the best (score of 0)
to the worst (score of 5) rating for that statement.10
The scores for each of the eight items are then added
up to give one final score (with a minimum of 0 and a
maximum score of 40). The higher the value of the
total score, the worse the health status of the individual.
The internal consistency (Cronbach a¼ 0.88) was high
for total score, as well as having good reproducibility
(interclass correlations [ICC] ¼ 0.80).
The mMRC dyspnoea score is obtained from a
questionnaire consisting of five statements, which
provide a measure of perceived breathlessness. For
statistical purposes, participants were divided by
dyspnoea scale category with the ‘mild to moderate
category’ consisting of patients who obtained a score
of ‘1’ or ‘2’ on the mMRC and the ‘severe to very
severe category’ for those scoring a ‘3’ or ‘4’. Fifteen
participants had an mMRC dyspnoea score of 1; 14
had an mMRC score of 2 (n¼ 14) and 10 individuals,
respectively, had an mMRC score of 3 and 4 (n¼ 10).
Ethical considerations
An information letter was provided to participants
with details regarding the nature of the study. Partici-
pants were also informed that they could withdraw
from the research study at any point in time. Informed
consent was requested as an indication of their volun-
tary participation in the rehabilitation programme. All
data collected from the participants were coded to
ensure patient confidentiality. Ethical approval was
obtained from the relevant institutional research
ethics committee (191/2011).
Statistical analysis
Statistical analysis was conducted using the Statistical
Package for Social Science (SPSS) software version 23.
Baseline characteristics and exercise data are
presented as mean + standard deviation (SD). In
order to examine changes in scores obtained at
baseline, with those obtained on completion of the
programme at 12 weeks and then on follow-up at
28 weeks, the paired samples t-test was used. This test
is appropriate when the samples comprise matched
pairs, typically found in ‘before–after’ studies. Data
were checked for normality using the Shapiro–Wilk test
and were confirmed to be normally distributed.
The responsiveness of the two tools for health
status (i.e. CAT and SGRQ) was determined by com-
putation of the effect size (ES). Responsiveness can
be defined as being the ability to measure the clini-
cally important change obtained from an outcome
measure. The ES was computed as recommended by
Field28 using the following equation:
r ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
t2
t2 þ df
s
where r is the ES and t and df are the values of the
t-statistic and degrees of freedom computed in the
paired samples t-test. The greater the ES, the greater
is the responsiveness of that tool. To interpret this,
scores greater than 0.2, 0.5 and 0.8 were used to rep-
resent the modest, moderate and great sensitivity,
respectively.29
Results
Sixty patients accepted to participate and consenting
participants were enrolled into a 12-week PR pro-
gramme. Of the 60 patients recruited, 49 patients com-
pleted the full programme (6 females and 43 males).
The reasons provided for not completing the PR pro-
gramme were perceiving no benefit in participation
(n ¼ 3), personal reasons (n ¼ 2) and transportation
difficulties (n¼ 6). The mean age of study participants
was that of 66 years (SD: 7.76), with a mean weight of
75 kg (SD: 14.97) and height of 164 cm (SD: 7.54).
Following a 12-week PR programme, significant
reductions in mean scores were identified for both the
SGRQ and CAT, indicating an improvement in the
health status of COPD participants following rehabi-
litation as is graphically shown in figure 1. These
improvements were also registered 4 months after
completion of the PR programme at the 28th week
time frame as is shown in Figure 2.
As presented in Table 1, both the SGRQ
(ES ¼ 0.87) and CAT (ES ¼ 0.75) displayed good
responsiveness by total sample for the 12-week
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rehabilitation programme. Responsiveness for the
three domains of SGRQ was the highest for the
impact domain (ES¼ 0.81), followed by the symptom
domain (ES ¼ 0.76) and the activity domain (ES ¼
0.71), respectively, by total sample.
An analysis of ESs demonstrates the greater
responsiveness of the SGRQ (SGRQ: mMRC 1–2,
ES ¼ 0.85; mMRC 3–4, ES ¼ 0.91) relative to the
CAT (mMRC 1–2, ES ¼ 0.78; mMRC 3–4, ES ¼
0.76) by dyspnoea severity category and for total
score. The difference in ESs between the two tools
(SGRQ: ES ¼ 0.91; CAT: ES ¼ 0.76) is most con-
spicuous for patients having higher dyspnoea severity
scores (i.e. mMRC 3–4).
An analysis of the responsiveness of the SGRQ by
domain and dyspnoea severity category indicates a
similar responsiveness on the impact domain (i.e.
mMRC 1–2, ES ¼ 0.83; mMRC 3–4 ES ¼ 0.83) and
a higher responsiveness on the activity and symptom
domains for patients having higher dyspnoea severity
scores (mMRC 3–4: activity, ES ¼ 0.76; symptom,
ES ¼ 0.85) relative to those in the mild to moderate
dyspnoea category (mMRC 1–2: activity, ES ¼ 0.68,
symptom, ES ¼ 0.69).
At the 28-week follow-up, the SGRQ (ES ¼ 0.75)
and the CAT (ES ¼ 0.74) demonstrated similar
responsiveness by total score (Table 2). Responsive-
ness for the three domains of the SGRQ was the high-
est for the impact domain (ES ¼ 0.71), followed by
the activity domain (ES ¼ 0.68) and the symptom
domain (ES ¼ 0.64), respectively (Table 2).
However, an analysis of the responsiveness of the
tools by dyspnoea severity category for total score
indicates that for the mild to moderate grouping (i.e.
mMRC 1–2), the CAT (ES ¼ 0.72) has a higher
responsiveness than the SGRQ (ES ¼ 0.66). How-
ever, for patients having higher dyspnoea scores
(mMRC 3–4), the responsiveness of the SGRQ
(ES ¼ 0.74) was greater than the CAT (ES ¼ 0.71)
for total score. Furthermore, a greater responsiveness
was identified in all domains of the SGRQ for
patients having higher dyspnoea severity scores
(mMRC 3–4: impact, ES ¼ 0.83; activity, ES ¼
0.79; symptom, ES ¼ 0.77) relative to those having
milder dyspnoea scores (mMRC 1–2: impact, ES ¼
0.81; activity, ES ¼ 0.68; symptom, ES ¼ 0.6).
Discussion
This article contributes to the academic literature by
examining the responsiveness of two measures
(SGRQ and CAT) of health status, with a sample of
COPD patients undergoing a 12-week PR programme
and on follow-up at 28 weeks. The identification of a
tool which is most responsive to changes is important,
as health status is a predictor of COPD exacerbation,
hospitalization, mortality and higher healthcare
expenditure, due to higher medical needs and hospital
doctor consultations.30
The results concur with those obtained in various
studies (Chaplin et al.,31 Dodd et al.,32 Kon et al.33
and Jones et al.34), which demonstrates the good
responsiveness of both tools in assessing the health
status of COPD patients. However, this study contri-
butes to the existing literature as it examines the
responsiveness of the SGRQ and the CAT by severity
of dyspnoea category. Such information is relevant
Figure 1. Graph showing changes in scores obtained with
the SGRQ and the CAT at baseline and following a 12-week
pulmonary rehabilitation programme. SGRQ: St. George’s
Respiratory Questionnaire; CAT: chronic obstructive pul-
monary disease assessment test.
Figure 2. Change in scores for health status using the
SGRQ and CAT between baseline and at follow-up (28
weeks). SGRQ: St. George’s Respiratory Questionnaire;
CAT: chronic obstructive pulmonary disease assessment
test.
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when considering that higher levels of dyspnoea in
COPD patients and the perceived benefit of such PR
programmes predict both attendance and completion
of PR programmes. Hence, the identification of a
tool with a greater responsiveness to detect the change
in health status by severity of the dyspnoea category
could enable the introduction of individualized
programmes in COPD patients.26
Highlighting that this article contributes to
available literature by comparing the responsiveness
Table 1. Change in health status measures between baseline and end of rehabilitation at 12 weeks.a
Health status measure
Mean at
baseline (SD)
Mean at end
of PR (SD) Mean change SEM ES t (df)
SGRQ total score Total sample 43.40 (14.88) 22.33 (13.37) 21.07 (11.81) 1.69 0.87 12.49b (48)
mMRC 1–2 38.09 (13.18) 18.69 (13.49) 19.41 (12.25) 2.27 0.85 8.53b (28)
mMRC 3–4 51.10 (14.07) 27.60 (11.57) 23.50 (11.01) 2.46 0.91 9.55b (19)
SGRQ activity score Total sample 58.03 (18.97) 38.68 (21.54) 19.34 (19.35) 2.76 0.71 6.99b (48)
mMRC 1–2 50.75 (16.28) 32.01 (19.88) 18.74 (20.58) 3.82 0.68 4.90b (28)
mMRC 3–4 68.57 (17.89) 48.36 (20.57) 20.21 (17.90) 4.00 0.76 5.05b (19)
SGRQ impact score Total sample 35.65 (17.81) 13.45 (11.31) 22.19 (15.98) 2.28 0.81 9.721b (48)
mMRC 1–2 29.92 (14.63) 10.93 (11.98) 18.99 (13.13) 2.44 0.83 7.79b (28)
mMRC 3–4 43.96 (19.06) 17.12 (9.37) 26.85 (18.78) 4.20 0.83 6.39b (19)
SGRQ symptom score Total sample 45.76 (18.92) 23.00 (16.65) 22.76 (19.79) 2.827 0.76 8.05b (48)
mMRC 1–2 41.93 (21.34) 20.99 (17.22) 20.94 (22.01) 4.09 0.69 5.12b (28)
mMRC 3–4 51.32 (13.36) 25.93 (15.76) 25.40 (16.23) 3.63 0.85 6.99b (19)
CAT total score Total sample 13.90 (8.903) 5.33 (5.77) 8.571 (7.539) 1.077 0.75 7.96b (48)
mMRC 1–2 11.38 (6.15) 4.14 (4.52) 7.24 (5.84) 1.084 0.78 6.68b (28)
mMRC 3–4 17.55 (10.99) 7.05 (6.98) 10.50 (9.32) 2.08 0.76 5.04b (19)
SD: standard deviation; PR: pulmonary rehabilitation; ES: effect size; df: degrees of freedom; SEM: standard mean error; t: t-statistic
value; SGRQ: St. George’s Respiratory Questionnaire; mMRC: modified Medical Research Council; CAT: chronic obstructive pulmon-
ary disease assessment test.
aSeverity of dyspnoea category: mild to moderate cases (mMRC 1–2) and severe to very severe cases (mMRC 3–4).
bSignificant at <0.001 level (one tailed).
Table 2. Mean scores, significance of change (t-test) and ESs from baseline to the 28-week follow-up.a
Health status measure
Mean at
baseline (SD)
Mean at follow-up
(28 weeks) Mean change SEM ES t
SGRQ total score Total sample 43.40 (14.88) 25.63 (15.42) 17.77 (15.96) 2.28 0.75 7.79b (48)
mMRC 1–2 38.09 (13.18) 19.58 (12.26) 18.51 (13.66) 2.54 0.66 7.30b (28)
mMRC 3–4 51.10 (14.07) 28.30 (16.45) 22.80 (13.96) 3.12 0.74 7.30b (19)
SGRQ activity score Total sample 58.03 (18.97) 37.48 (19.63) 20.54 (22.45) 3.21 0.68 6.41b (48)
mMRC 1–2 50.75 (16.28) 29.34 (18.41) 21.41 (23.34) 4.33 0.68 4.94b (28)
mMRC 3–4 68.57 (17.89) 43.68 (20.49) 24.89 (19.45) 4.35 0.79 5.72b (19)
SGRQ impact score Total sample 35.65 (17.81) 18.18 (14.35) 17.47 (17.62) 2.52 0.71 6.94b (48)
mMRC 1–2 29.92 (14.63) 12.92 (10.04) 17.00 (12.69) 2.36 0.81 7.22b (28)
mMRC 3–4 43.96 (19.06) 18.82 (15.93) 25.14 (17.63) 3.94 0.83 6.38b (19)
SGRQ symptom score Total sample 45.76 (18.92) 28.56 (18.88) 17.20 (20.75) 2.96 0.64 5.80b (48)
mMRC 1–2 41.93 (21.34) 23.90 (19.10) 18.03 (20.93) 3.89 0.66 4.64b (28)
mMRC 3–4 51.32 (13.35) 30.85 (18.55) 20.47 (17.48) 3.908 0.77 5.24b (19)
CAT total score Total sample 13.52 (8.61) 5.24 (5.79) 8.29 (7.99) 1.23 0.74 6.71b (41)
mMRC 1–2 11.38 (6.15) 4.28 (4.54) 7.10 (7.00) 1.30 0.72 5.46b (28)
mMRC 3–4 17.55 (10.99) 8.30 (8.08) 9.25 (9.51) 2.13 0.71 4.35b (19)
SD: standard deviation; PR: pulmonary rehabilitation; ES: effect size; df: degrees of freedom; SEM: standard mean error; t: t-statistic
value; SGRQ: St. George’s Respiratory Questionnaire; mMRC: modified Medical Research Council; CAT: chronic obstructive pulmon-
ary disease assessment test.
aSeverity of dyspnoea category: mild to moderate cases (mMRC 1–2) and severe to very severe cases (mMRC 3–4).
bSignificant at <0.001 level (one tailed).
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of the CAT and SGRQ by severity of dyspnoea cate-
gory, greater ESs were obtained with the SGRQ at the
end of the 12-week PR programme. The difference in
ESs is most apparent for patients with severe to very
severe dyspnoea (mMRC 3–4: SGRQ¼ 0.91; CAT¼
0.76). This may be explained as the factors contribut-
ing to the CAT scores differ slightly to those for the
SGRQ.35 Thus, the greater responsiveness of the
SGRQ at the end of PR may arise as physiologic
measures (relating to greater severity of dyspnoea)
such as airflow limitation and exercise capacity are
significant contributors to variance for the total scores
of the SGRQ but not for the CAT. Furthermore, the
study has demonstrated that the specific domains of
the SGRQ also show good responsiveness, providing
the clinician with information regarding changes
experienced in relation to symptoms, activity and
impact of the disease. Additionally, at the end of the
12-week PR programme, the impact domain showed
the highest responsiveness and the activity domain
showed the least responsiveness by total sample and
for the mMRC 1–2 category (mild–moderate dys-
pnoea). On the other hand, for participants in the
severe to very severe dyspnoea category (mMRC
3–4), the symptom domain showed the highest
responsiveness (ES ¼ 0.85) and the activity domain
showed the least responsiveness (ES ¼ 0.76). This is
interesting as severity of breathlessness is a predictor
of non-adherence to PR programmes and so the use of
the SGRQ enables the clinician to assess any symp-
toms which might gauge the progression of treatment
for that patient. Moreover, the levels of various symp-
toms experienced by COPD patients can be predictors
for COPD exacerbations and increased risk of
mortality.30 Thus, the findings from this study demon-
strate that although both tools have good responsive-
ness at the end of PR, the SGRQ provides an
additional advantage of displaying a greater respon-
siveness, especially in relation to patients with severe
to very severe dyspnoea (mMRC 3–4). This identifi-
cation of a tool which can detect a change in health
status is of importance, considering that severity of
dyspnoea and perceived benefit of PR influence non-
completion of PR programmes. Furthermore, the
good responsiveness obtained for the specific
domains on the SGRQ would also enable the provi-
sion of individual management care plans which not
only target the individual’s health status in general but
which may also target the individual domains.
The results obtained at the 28-week follow-up
period demonstrate that both tools show similar levels
of responsiveness (SGRQ, ES ¼ 0.75; CAT, ES ¼
0.74). Moreover, the ‘impact’ domain had the highest
responsiveness and the ‘symptom’ domain showed the
least responsiveness by total sample and dyspnoea
severity categories (i.e. mMRC group 1–2 and mMRC
group 3–4). Therefore, both at the end of rehabilitation
and at 28-week follow-up, the impact domain had the
highest responsiveness, except for the mMRC 3–4
category where the symptom domain showed the high-
est responsiveness at the end of the 12-week rehabilita-
tion programme. This information underscores the
importance to the clinician of understanding the inde-
pendent contributions of these domains, as well as the
differences in responsiveness of these domains depend-
ing on their severity of dyspnoea category. Thus, both
the SGRQ and CAT can be used to detect changes in
health status at 28-week follow-up, although the SGRQ
provides additional information in relation to the spe-
cific domains.
The need to select an appropriate tool to evaluate
health status is relevant as it well documented25,30 that
a poor health status is associated with adverse out-
comes among which depression.36 In addition, depres-
sion has been demonstrated to be a significant predictor
of non-completion of PR programmes, which are so
essential in the care of persons with COPD.24
Thus, the present study highlights the greater
responsiveness of the SGRQ relative to the CAT, in
particular with patients having severe dyspnoea at the
end of the PR programme, whereas a similar level of
responsiveness, for both the CAT and SGRQ, was
obtained at the 28-week follow-up period. Hence,
by identifying changes in health status in such
patients, one may provide individualized programmes
which are responsive to their needs.
A limitation of this study is the small sample size.
Although the research is conducted at the only general
state hospital with a national capture potential, it is
recommended by the authors that this study is
repeated in order to analyse the trend identified with
a larger sample size, hence enabling generalization.
Furthermore, the sample in this study is somewhat
biased in favour of male participants rather than
females, owing to the opportunistic and ethical influ-
ences on the data collection process
Conclusion
This study demonstrates that both the CAT and
SGRQ have good responsiveness and can detect
changes in health status for COPD patients.
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However, an analysis of results by severity of dys-
pnoea indicates the greater responsiveness of the
SGRQ, especially in relation to patients presenting
as severe cases of dyspnoea (mMRC 3–4) for COPD
at the end of PR programme, whereas at 28-week
follow-up, both tools show similar responsiveness
by dyspnoea category and by total sample.
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